文献速递类风湿关节炎脊柱关节炎系统性红斑狼疮

利用多基因风险评分辅助早期炎性关节炎患者的诊断:来自诺福克关节炎登记的研究结果

Using Polygenic Risk Scores to Aid Diagnosis of Patients With Early Inflammatory Arthritis: Results From the Norfolk Arthritis Register.
PubMed 文献 · Arthritis Rheumatol · 2024-01-17

该研究在诺福克关节炎登记(NOAR)这一前瞻性观察队列中,对1047例早期炎性关节炎患者评估了遗传概率工具(G-PROB)辅助诊断的表现。G-概率与临床医生诊断的校准回归系数为1.047,合并曲线下面积(95%CI)为0.85(0.84-0.86),G-概率<5%时阴性预测值为96.0%,>50%时阳性预测值为70.4%,55.7%的患者最高G-概率对应的疾病与临床诊断一致。作者认为G-PROB可将复杂遗传信息转化为有意义且可解释的条件概率,可能尤其有助于在风湿免疫科门诊排除不太可能的诊断。

要点

  • 在1047例早期炎性关节炎患者中,G-概率区分临床医生诊断的合并AUC(95%CI)为0.85(0.84-0.86)。
  • G-概率<5%对应阴性预测值96.0%,94%的患者可提示>2种不太可能的疾病,53.7%可提示>3种。
  • G-概率>50%对应阳性预测值70.4%,55.7%的患者最高G-概率对应疾病与临床诊断一致。

核心结论

  • G-PROB将复杂遗传信息转化为有意义且可解释的条件概率,可能尤其有助于在风湿免疫科门诊排除不太可能的诊断。

研究设计与样本

  • 研究数据来自诺福克关节炎登记(NOAR),该登记为前瞻性观察队列,纳入表现为早期炎性关节炎的患者。
  • 研究获取患者的基因型与临床医生诊断,基于已发表遗传风险变异的已知疾病相关比值比,为每例患者生成6个G-概率(0%-100%),分别对应类风湿关节炎、系统性红斑狼疮、银屑病关节炎、脊柱关节病、痛风或「其他疾病」。
  • 研究评估G-概率与临床医生诊断相比的表现,共对1047例患者测试G-PROB。

主要发现

  • G-概率与临床医生诊断的校准度高,回归系数为1.047,1.00为理想值。
  • G-概率区分临床医生诊断的合并曲线下面积(95%CI)为0.85(0.84-0.86)。
  • G-概率<5%对应阴性预测值96.0%,此时94%的患者可提示>2种不太可能的疾病,53.7%的患者可提示>3种。
  • G-概率>50%对应阳性预测值70.4%。
  • 55.7%的患者中,最高G-概率对应的疾病与临床医生诊断一致。

关键数值与推荐

  • G-概率<5%对应阴性预测值96.0%,用于提示不太可能的疾病。
  • G-概率>50%对应阳性预测值70.4%。
  • 最高G-概率对应疾病与临床医生诊断一致的患者比例为55.7%。

临床怎么用

  • 作者认为G-PROB可能尤其有助于在风湿免疫科门诊排除不太可能的诊断。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: There is growing evidence that genetic data are of benefit in the rheumatology outpatient setting by aiding early diagnosis. A genetic probability tool (G-PROB) has been developed to aid diagnosis has not yet been tested in a real-world setting. Our aim was to assess whether G-PROB could aid diagnosis in the rheumatology outpatient setting using data from the Norfolk Arthritis Register (NOAR), a prospective observational cohort of patients presenting with early inflammatory arthritis. METHODS: Genotypes and clinician diagnoses were obtained from patients from NOAR. Six G-probabilities (0%-100%) were created for each patient based on known disease-associated odds ratios of published genetic risk variants, each corresponding to one disease of rheumatoid arthritis, systemic lupus erythematosus, psoriatic arthritis, spondyloarthropathy, gout, or "other diseases." Performance of the G-probabilities compared with clinician diagnosis was assessed. RESULTS: We tested G-PROB on 1,047 patients. Calibration of G-probabilities with clinician diagnosis was high, with regression coefficients of 1.047, where 1.00 is ideal. G-probabilities discriminated clinician diagnosis with pooled areas under the curve (95% confidence interval) of 0.85 (0.84-0.86). G-probabilities <5% corresponded to a negative predictive value of 96.0%, for which it was possible to suggest >2 unlikely diseases for 94% of patients and >3 for 53.7% of patients. G-probabilities >50% corresponded to a positive predictive value of 70.4%. In 55.7% of patients, the disease with the highest G-probability corresponded to clinician diagnosis. CONCLUSION: G-PROB converts complex genetic information into meaningful and interpretable conditional probabilities, which may be especially helpful at eliminating unlikely diagnoses in the rheumatology outpatient setting.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Hum RM, Sharma SD, Stadler M, et al. Using Polygenic Risk Scores to Aid Diagnosis of Patients With Early Inflammatory Arthritis: Results From the Norfolk Arthritis Register. Arthritis Rheumatol. 2024. PMID: 38010198. doi:10.1002/art.42760

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。